Fluidigm-Singapore completes final milestone toward full manufacturing operations
Off-shore fab positions Fluidigm to move rapidly into the real-time qPCR market
"We view our Singapore operation as critical to our long-term success," said Fluidigm CEO Gajus Worthington. "This group has proven its mettle with production of our first product, TOPAZ® screening chips. Now, we are poised for high-volume, low-cost manufacturing to meet the demand in a much larger market." Manufacturing engineers at corporate headquarters in South San Francisco collaborated with the Singapore team to bring the facility up to speed. The off-shore strategy takes advantage of Singapore's high-quality talent, which is a legacy of its semiconductor industry.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.